Skip to main content

Peer Review reports

From: Durvalumab in frail and elderly patients with stage four non-small cell lung cancer: Study protocol of the randomized phase II DURATION trial

Original Submission
25 Oct 2019 Submitted Original manuscript
27 Dec 2019 Reviewed Reviewer Report - Andreas M Schmitt
30 Dec 2019 Reviewed Reviewer Report - Benjamin Kasenda
15 Jan 2020 Reviewed Reviewer Report - Jack Grierson
26 Feb 2020 Author responded Author comments - Jonas Kuon
5 Mar 2020 Reviewed Reviewer Report - Jack Grierson
8 Mar 2020 Reviewed Reviewer Report - Benjamin Kasenda
10 Mar 2020 Reviewed Reviewer Report - Andreas M Schmitt
20 Mar 2020 Author responded Author comments - Jonas Kuon
Resubmission - Version 2
26 Feb 2020 Submitted Manuscript version 2
Publishing
24 Mar 2020 Editorially accepted
22 Apr 2020 Article published 10.1186/s13063-020-04280-8

You can find further information about peer review here.

Back to article page